Modulation of human TRPV1 receptor activity by extracellular protons and host cell expression system

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 20-30

  Bianchi, Bruce R ^a   Lee, Chih Hung ^a   Jarvis, Michael F ^a   El Kouhen, Rachid ^a   Moreland, Robert B ^a   Faltynek, Connie R ^a   Puttfarcken, Pamela S ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Anandamide; Capsaicin; Ligand gated ion channel; Pain; Protons; TRPV1 (transient receptor potential vanilloid 1)

Indexed keywords

5' IODORESINFERATOXIN; A 425619; ACID; ANANDAMIDE; CAPSAICIN; CAPSAZEPINE; DOPAMINE DERIVATIVE; N ARACHIDONOYLDOPAMINE; N OLEOYLDOPAMINE; PROTON; RECEPTOR BLOCKING AGENT; RECOMBINANT RECEPTOR; RUTHENIUM RED; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ACIDITY; ARTICLE; ASTROCYTE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; EMBRYO CELL; GENE EXPRESSION SYSTEM; GLIA CELL; HOST CELL; HUMAN; HUMAN CELL; KIDNEY CELL; MODULATION; PRIORITY JOURNAL;

CALCIUM; CELL LINE; HUMANS; HYDROGEN-ION CONCENTRATION; PROTONS; TRPV CATION CHANNELS;

EID: 33646152536     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.003     Document Type: Article

References (39)

1. Al-Hayani A., Wease K.N., Ross R.A., Pertwee R.G., and Davies S.N. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41 (2001) 1000-1005
2. Bender F.L.P., Schnitzler M.M., Li Y., Ji A., Weihe E., Gudermann T., and Schafer M.K.-H. The temperature-sensitive ion channel TRPV2 is endogenously expressed and functional in the primary sensory cell line F-11. Cell. Physiol. Biochem. 15 (2005) 183-194
3. Caterina M.J., and Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24 (2001) 487-517
4. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
5. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A., and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
6. Chu C.J., Huang S.M., De Petrocellis L., Bisogno T., Ewing S.A., Miller J.D., Zipkin R.E., Daddario N., Appendino G., Di Marzo V., and Walker J.M. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem. 278 (2003) 13633-13639
7. Cortright D.N., Crandall M., Sanchez J.F., Zou T., Krause J.E., and White G. The tissue distribution and functional characterization of human VR1. Biochem. Biophys. Res. Commun. 281 (2001) 1183-1189
8. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., and Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405 (2000) 183-187
9. El Kouhen R., Surowy C.S., Bianchi B.R., Neelands T.R., McDonald H.A., Niforatos W., Gomtsyan A., Lee C.H., Honore P., Sullivan J.P., Jarvis M.F., and Faltynek C.R. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid. J. Pharmacol. Exp. Ther. 314 (2005) 400-409
10. Gunthorpe M.J., Smith G.D., Davis J.B., and Randall A.D. Characterisation of a human acid-sensing ion channel (hASIC1a) endogenously expressed in HEK293 cells. Pflugers Arch.-Eur. J. Physiol. 442 (2001) 668-674
11. Hayes P., Meadows H.J., Gunthorpe M.J., Harries M.H., Duckworth D.M., Cairns W., Harrison D.C., Clarke C.E., Ellington K., Prinjha R.K., Barton A.J.L., Medhurst A.D., Smith G.D., Topp S., Murdock P., Sanger G.J., Terrett J., Jenkins O., Benham C.D., Randall A.D., Gloger I.S., and Davis J.B. Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain 88 (2000) 205-215
12. Honore P., Wismer C.T., Mikusa J., Zhu C.Z., Zhong C., Gauvin D.M., Gomtsyan A., El Kouhen R., Lee C.H., Marsh K., Sullivan J.P., Faltynek C.R., and Jarvis M.F. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J. Pharmacol. Exp. Ther. 314 (2005) 410-421
13. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., and Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8400-8405
14. Hwang S.W., Cho H., Kwak J., Lee S.-Y., Kang C.-J., Jung J., Cho S., Min K.H., Suh Y.-G., Kim D., and Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6155-6160
15. Jerman J.C., Brough S.J., Prinjha R., Harries M.H., Davis J.B., and Smart D. Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology. Br. J. Pharmacol. 130 (2000) 916-922
16. Jordt S.E., Tominaga M., and Julius D. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8134-8135
17. Julius D., and Basbaum A. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
18. Kwak J.Y., Jung J.Y., Hwang S.W., Lee W.T., and Oh H. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: evidence for an endogenous capsaicin-like substance. Neuroscience 86 (1998) 619-626
19. Liapi A., and Wood J.N. Extensive co-localization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex. Eur. J. Neurosci. 22 (2005) 825-834
20. Marinelli S., Vaughan C.W., Christie M.J., and Connor M. Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J. Physiol. 543 (2002) 531-540
21. Marinelli S., Di Marzo V., Berretta N., Matias I., Maccarrone M., Bernardi G., and Mercuri N.B. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J. Neurosci. 23 (2003) 3136-3144
22. McGaraughty S., Chu K.L., Bitner R.S., Martino B., El Kouhen R., Han P., Nikkel A.L., Burgard E.C., Faltynek C.R., and Jarvis M.F. Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM. J. Neurophysiol. 90 (2003) 2702-2710
23. McIntyre P., McLatchie L.M., Chambers A., Phillips E., Clarke M., Savidge J., Toms C., Peacock M., Shah K., Winter J., Weerasakera N., Webb M., Rang H.P., Bevan S., and James I.F. Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br. J. Pharmacol. 132 (2001) 1084-1094
24. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., and Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3655-3660
25. Roberts J.C., Davis J.B., and Benham C.D. [3H]-Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 995 (2004) 176-183
26. Sanchez J.F., Krause J.E., and Cortright D.N. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat. Neuroscience 107 (2001) 373-381
27. Santos A.R.S., and Calixto J.B. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci. Lett. 235 (1997) 73-76
28. Sasamura T., and Kuraishi Y. Peripheral and central actions of capsaicin and VR1 receptor. Jpn. J. Pharmacol. 80 (1999) 275-280
29. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., and Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129 (2000) 227-230
30. Smart D., Jerman J.C., Gunthorpe M.J., Brough S.J., Ranson J., Cairns W., Hayes P.D., Randall A.D., and Davis J.B. Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur. J. Pharmacol. 417 (2001) 51-58
31. Szabo T., Biro T., Gonzalez A.F., Palkovits M., and Blumberg P.M. Pharmacological characterization of vanilloid receptor located in the brain. Brain Res. Mol. Brain Res. 98 (2002) 51-57
32. Szallasi A., and Blumberg P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51 (1999) 159-212
33. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., and Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21 (1998) 531-543
34. Tominaga M., Wada M., and Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl. Acad. Sci. 98 (2001) 6951-6956
35. Toth A., Boczan J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I., Csiba L., and Blumberg P.M. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res. Mol. Brain Res. 135 (2005) 162-168
36. Toth A., Wang Y., Kedei N., Tran R., Pearce L.V., Kang S.U., Jin M.K., Choi H.K., Lee J., and Blumberg P.M. Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1. Life Sci. 76 (2005) 2921-2932
37. Vellani V., Mapplebeck S., Moriondo A., Davis J.B., and McNaughton P.A. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol. 534.3 (2001) 813-825
38. Wahl P., Foged C., Tullin S., and Thomsen C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol. Pharmacol. 59 (2001) 9-15
39. Witte D.G., Cassar S.C., Masters J.N., Esbenshade T., and Hancock A.A. Use of a fluorescent imaging plate reader-based calcium assay to assess pharmacological differences between the human and rat vanilloid receptor. J. Biomol. Screen. 7 5 (2002) 466-475